Children aged 12-17 must wait 12 weeks after catching Covid before getting jabbed because it may reduce their risk of rare heart complication, health chiefs rule
- Vaccine advisory panel said evidence longer gap reduces the risk of myocarditis
- Heart inflammation complication is very rare side effect suffered by jabbed kids
- Twelve to 15-year-olds are still only being offered one dose of Pfizer’s vaccine
Children should wait at least 12 weeks after catching Covid to get their jab, Britain’s vaccine advisory panel recommended today.
The Joint Committee on Vaccination and Immunisation (JCVI) said there was evidence the longer gap reduces the risk of myocarditis, a type of heart inflammation reported in a small number of children after vaccination.
The change in guidance applies only to healthy children aged 12 to 17.
Youngsters who caught Covid previously only had to wait four weeks, which remains the advice for adults over the age of 18 and children extremely vulnerable to Covid.
Twelve to 15-year-olds are still only being offered one dose of Pfizer’s vaccine while officials monitor myocarditis rates in other countries.
But as of this week, 16 and 17-year-olds can now come forward for the second jab after the UK’s regulator decided the benefit of the jabs ‘clearly’ outweighed the risk.
So far, more than half of older teenagers have come forward for a first dose and nearly a third of 12 to 15-year-olds have had the initial jab.
Fifteen-year-old Quinn Foakes receiving a Covid-19 vaccination at Belfairs Academy in Leigh-on-Sea, Essex, in September
The UK Health Security Agency, which announced the move today, admitted that it would slow down the rollout of the country’s vaccine programme.
But it insisted children should still have high levels of natural immunity, given that half of secondary-aged pupils are thought to have already had the virus.
The agency, which replaced Public Health England last month, said natural infection provided good protection against re-infection for three to six months.
A major study in Israel today found that protection from two doses of Pfizer’s vaccine wanes at a similar point. Immunity from a single dose falters more quickly.
UK Government data justifying today’s update shows nine in every million under-18s in the UK will get myocarditis after a single dose of Pfizer’s Covid jab, the same as around one per 110,000.
But for every million doses of the vaccine administered to children, it will prevent around 150 hospitalisations from Covid.
The JCVI held off on recommending second doses for children because real-world data from Israel and the US suggested the myocarditis risk is as high as one in 10,000.
But real-world UK data in slightly older adults – who also saw above normal rates of myocarditis in other countries – was not higher after the second jab .
This is thought to be because the dosing gap between doses here is 12 weeks, whereas it’s between three and four weeks in the US and Israel.
The JCVI believes that 12-week gap might also be the sweet spot for getting a jab after natural infection in young people, which prompted today’s guidance tweak.
There is also evidence that rates of myocarditis in Britain are similar in 16 and 17-year-olds and 18 to 29-year-olds, after the second jab.
This is why the JCVI recommend two jabs for healthy older teens earlier this week. But it is still weighing up the evidence on younger children.
It is unclear why the longer space between vaccination or natural infection reduces the risk of myocarditis yet.
But the leading theory is that the gap gives the immune system time to calm down from the reaction to the first dose or infection.
Myocarditis is an inflammation of the heart muscle and happens when the body’s immune system reacts to an infection or some other trigger.
During Covid infection or immunisation, the body produces cells to fight the virus. If the disease-fighting cells enter the heart, they can inflame the muscle.